Their studies demonstrate that increased α2,6-sialylation on glioma cell surface may influence the anti-migratory effect of GnT-III, and overexpression of GnT-III significantly inhibits α2,3-sialylation but not α2,6-sialylation [107]. The gene discussed is MGAT3; the disease is glioma.